In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
BioMed X Launches a New Call for Application in Autoimmune Disease Research
Yahoo! Finance
BioMed X, a biomedical research institute, announced the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.
BioMed X Launches a New Call for Application in Autoimmune Disease Research
PharmiWeb
A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
BioMed X Launches a New Call for Application in Autoimmune Disease Research
MarketWatch
BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.
BioMed X Launches a New Call for Application in Autoimmune Disease Research
BioSpace
A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
BioMed X and AbbVie Start New Research Project in the USA
Newswire
BioMed X inaugurates its new institute in the USA with a research project on complex ex vivo models of tissue inflammation in collaboration with AbbVie.
BioMed X and AbbVie Start New Research Project in the USA
Yahoo! Finance
BioMed X, an independent biomedical research institute, announces the start of a research project in collaboration with AbbVie to be hosted by the new BioMed X Institute in New Haven, CT, USA. The project aims to generate an organotypic human arterial model with sufficient complexity to recapitulate key characteristics of chronic autoimmune disease onset, progression, and resolution, with the long-term…
The BioMed X Institute: BioMed X and AbbVie Start New Research Project in the USA
FinanzNachrichten
BioMed X, an independent biomedical research institute, announces the start of a research project in collaboration with AbbVie to be hosted by the new BioMed X Institute in New Haven, CT, USA.
BioMed X and AbbVie Start New Research Project in the USA
Bloomberg
BioMed X inaugurates its new institute in the USA with a research project on complex ex vivo models of tissue inflammation in collaboration with AbbVie.